JP2011085586A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011085586A5 JP2011085586A5 JP2010229934A JP2010229934A JP2011085586A5 JP 2011085586 A5 JP2011085586 A5 JP 2011085586A5 JP 2010229934 A JP2010229934 A JP 2010229934A JP 2010229934 A JP2010229934 A JP 2010229934A JP 2011085586 A5 JP2011085586 A5 JP 2011085586A5
- Authority
- JP
- Japan
- Prior art keywords
- pct
- acute stroke
- patient
- ischemic attack
- bacterial infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09012947 | 2009-10-13 | ||
| EP09012947.9 | 2009-10-13 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014237837A Division JP2015057611A (ja) | 2009-10-13 | 2014-11-25 | 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011085586A JP2011085586A (ja) | 2011-04-28 |
| JP2011085586A5 true JP2011085586A5 (https=) | 2013-05-09 |
| JP5722587B2 JP5722587B2 (ja) | 2015-05-20 |
Family
ID=41362428
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010229934A Active JP5722587B2 (ja) | 2009-10-13 | 2010-10-12 | 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス |
| JP2014237837A Withdrawn JP2015057611A (ja) | 2009-10-13 | 2014-11-25 | 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014237837A Withdrawn JP2015057611A (ja) | 2009-10-13 | 2014-11-25 | 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8383332B2 (https=) |
| EP (1) | EP2320237B1 (https=) |
| JP (2) | JP5722587B2 (https=) |
| CN (1) | CN102081101B (https=) |
| ES (1) | ES2601104T3 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103123359B (zh) * | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| US8383332B2 (en) | 2009-10-13 | 2013-02-26 | B.R.A.H.M.S. Gmbh | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
| ITRM20100121A1 (it) * | 2010-03-18 | 2011-09-19 | Univ Pisa | Marcatori molecolari per infezioni delle vie urinarie. |
| CN102305858B (zh) * | 2011-07-26 | 2013-08-21 | 深圳市国赛生物技术有限公司 | 一种检测降钙素原的试剂盒 |
| EP3367099B1 (en) | 2012-02-09 | 2021-05-26 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| BR112017002884A2 (pt) | 2014-08-14 | 2018-01-30 | Memed Diagnostics Ltd | ?análise computacional de dados biológicos por meio do uso de variedade e hiperplano? |
| CN111624345A (zh) | 2014-12-11 | 2020-09-04 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| EP3322988A1 (en) * | 2015-07-13 | 2018-05-23 | University of Geneva | Biomarker panels for brain injury complications |
| EP3423590A4 (en) | 2016-03-03 | 2020-02-26 | Memed Diagnostics Ltd. | DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS |
| AU2017246588A1 (en) * | 2016-04-08 | 2018-09-27 | Centre National De La Recherche Scientifique - Cnrs - | Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery |
| CN107490683A (zh) * | 2016-06-09 | 2017-12-19 | 常州博闻迪医药科技有限公司 | 一种唾液降钙素原胶体金检测方法 |
| CN107490679A (zh) * | 2016-06-09 | 2017-12-19 | 常州博闻迪医药科技有限公司 | 一种唾液降钙素原酶联免疫检测方法 |
| EP3482201B1 (en) | 2016-07-10 | 2022-12-14 | Memed Diagnostics Ltd. | Early diagnosis of infections |
| EP3482200B1 (en) | 2016-07-10 | 2022-05-04 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| WO2018114044A1 (en) * | 2016-12-22 | 2018-06-28 | University Of Geneva | Biomarker panels for brain injury complications |
| EP3438668A1 (en) | 2017-08-04 | 2019-02-06 | B.R.A.H.M.S GmbH | Diagnosis and risk stratification of fungal infections |
| WO2019053116A1 (en) | 2017-09-13 | 2019-03-21 | B.R.A.H.M.S Gmbh | FLUID THERAPY GUIDING METHOD BASED ON PROADRENOMEDULLINE |
| EP3971572A1 (en) | 2017-09-13 | 2022-03-23 | B.R.A.H.M.S GmbH | Proadrenomedullin as a marker for abnormal platelet levels |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
| WO2019122089A1 (en) | 2017-12-20 | 2019-06-27 | B.R.A.H.M.S Gmbh | Antibiotic therapy guidance based on pro-adm |
| JP7444776B2 (ja) * | 2017-12-20 | 2024-03-06 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス |
| EP3578989A1 (en) | 2018-06-06 | 2019-12-11 | B.R.A.H.M.S GmbH | Pro-adm for prognosis of trauma-related complications in polytrauma patients |
| EP4052042A1 (en) | 2019-10-28 | 2022-09-07 | F. Hoffmann-La Roche AG | Sepsis management |
| KR102362951B1 (ko) * | 2020-08-13 | 2022-02-14 | 연세대학교 원주산학협력단 | 프로칼시토닌 대 ｃ반응성 단백질의 비율을 이용한 허혈성 뇌졸중의 단기 사망률 예측 방법 |
| US20240221958A1 (en) | 2021-04-30 | 2024-07-04 | Roche Diagnostics Operations, Inc. | Pct marker panels for early detection of sepsis |
| EP4330681A2 (en) | 2021-04-30 | 2024-03-06 | Roche Diagnostics GmbH | Igfbp7 marker panels for early detection of sepsis |
| JP2024515086A (ja) | 2021-04-30 | 2024-04-04 | エフ． ホフマン－ラ ロシュ アーゲー | 敗血症の早期検出のためのｇｄｆ１５マーカーパネル |
| JP2024516681A (ja) | 2021-04-30 | 2024-04-16 | エフ． ホフマン－ラ ロシュ アーゲー | 敗血症の早期検出のためのｓＦｌｔ１マーカーパネル |
| WO2026013199A1 (en) | 2024-07-12 | 2026-01-15 | Cezanne S.A.S. | Clinical immunoassay with early signal measurement |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3147470A1 (de) | 1981-12-01 | 1983-07-14 | Bizerba-Werke Wilhelm Kraut GmbH & Co KG, 7460 Balingen | Kraftmessvorrichtung |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| DE112004001863T5 (de) * | 2003-10-03 | 2006-09-07 | Scantibodies Laboratory, Inc., Santee | Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität |
| CN101029897A (zh) * | 2007-02-09 | 2007-09-05 | 深圳市新产业生物医学工程有限公司 | 一种降钙素原测试试剂盒及其测试方法 |
| DE102007009751A1 (de) * | 2007-02-28 | 2008-09-04 | B.R.A.H.M.S Aktiengesellschaft | Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens |
| US8691595B2 (en) * | 2007-06-22 | 2014-04-08 | B.R.A.H.M.S. Gmbh | Method for detecting analytes |
| CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| EP2020603A1 (en) * | 2007-08-03 | 2009-02-04 | BRAHMS Aktiengesellschaft | Method for risk stratification in stable coronary artery disease |
| EP2101178A1 (en) * | 2008-03-12 | 2009-09-16 | BRAHMS Aktiengesellschaft | Use of Procalcitonin (PCT) in prognosis following acute coronary syndromes |
| GB0722729D0 (en) * | 2007-11-20 | 2007-12-27 | Bristol Myers Squibb Co | Diagnostic markers of wound infection |
| US8383332B2 (en) * | 2009-10-13 | 2013-02-26 | B.R.A.H.M.S. Gmbh | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
-
2010
- 2010-10-12 US US12/902,533 patent/US8383332B2/en active Active
- 2010-10-12 JP JP2010229934A patent/JP5722587B2/ja active Active
- 2010-10-12 ES ES10187310.7T patent/ES2601104T3/es active Active
- 2010-10-12 EP EP10187310.7A patent/EP2320237B1/en not_active Revoked
- 2010-10-13 CN CN201010510497.3A patent/CN102081101B/zh active Active
-
2014
- 2014-11-25 JP JP2014237837A patent/JP2015057611A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011085586A5 (https=) | ||
| Jekarl et al. | Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis | |
| AU2022228181B2 (en) | Improved Methods and Devices for Accurate Diagnosis of Infections | |
| RU2012142504A (ru) | Прокальцитонин для диагностики бактериальных инфекций и контроля лечения антибиотиками для пациентов с неспецифическими жалобами | |
| JP7579353B2 (ja) | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン | |
| JP2013527437A5 (https=) | ||
| WO2021204984A1 (en) | Biomarkers for the diagnosis of respiratory tract infections | |
| US10830774B2 (en) | Methods and compositions for diagnosis and treatment of meningitis | |
| US20250236913A1 (en) | New method to diagnose inflammatory diseases | |
| CN104698159A (zh) | 一种内毒素含量的检测方法 | |
| CN111094981B (zh) | Pct和pro-adm作为监测抗生素治疗的标记物 | |
| Jeon et al. | The value of procalcitonin and the SAPS II and APACHE III scores in the differentiation of infectious and non-infectious fever in the ICU: a prospective, cohort study | |
| RU2008123442A (ru) | Способ определения ранних лабораторных маркеров генерализации инфекции у больных острым миелобластным лейкозом при нейтропении | |
| Kassem et al. | Comparative study of ascitic fluid and serum levels of calprotectin, procalcitonin and endocan in patients with liver cirrhosis for early diagnosis and prediction of spontaneous bacterial peritonitis | |
| BR112020004138A2 (pt) | pro-adm como marcador de monitoramento terapêutico para pacientes doentes em estado crítico | |
| Şahintürk et al. | Neutrophil-to-Lymphocyte Ratio as a Potential Early Marker of Antibiotic Resistance in Patients with Infected Cirrhotic Ascites. | |
| Lo Buglio et al. | Reliability of serum procalcitonin concentration for the diagnosis of sepsis in elderly patient with chronic kidney disease | |
| Mandour et al. | Neutrophil Gelatinase-Associated Lipocalin-2 and Macrophage Antigen-1 in Cirrhotic Patients Infected with Carbapenem Resistant Enterobacteriaceae | |
| RU2820944C2 (ru) | Проадм для прогнозирования риска состояния, требующего госпитализации, у пациентов с симптомами инфекционного заболевания | |
| JP2013519083A5 (https=) | ||
| Lei et al. | Expression of Serum Immune Inflammatory Factors in Children with Suppurative Tonsillitis Caused by Adenovirus Infection and Its Correlation with Adenovirus Pneumonia | |
| Chen et al. | Diagnosis, Treatment, and Prevention of Acute-on-Chronic Liver Failure with Bacterial Infections | |
| CN109959796A (zh) | 一种人血清dkk1酶联适配体吸附检测试剂盒 | |
| Mutenta et al. | The diagnostic value of Neutrophil Gelatinase–Associated Lipocalin (NGAL) for detecting early phase sepsis in patients with suspected bacterial infection. | |
| CHOI et al. | The clinical value of procalcitonin in diagnosis of patients with fever |